Search Results

For the quantitative determination of Low-density lipoprotein cholesterol (LDL-C) in human serum or plasma. LDL Cholesterol is recognized as a useful tool in identifying patients who are at a higher risk for coronary heart diseas. High LDL cholesterol levels are associated with an increased risk. This reagent set is intended for in vitro diagnostic use only.

Not Found

The provided FDA document is a 510(k) premarket notification for a "Direct LDL Cholesterol Reagent." This is an in vitro diagnostic device, not an AI/ML medical device. Therefore, the concepts of acceptance criteria met by an algorithm, training and test sets, expert ground truth, MRMC studies, or standalone performance do not apply in the context of this document.

The document states that the device is "substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices." This means its performance is considered comparable to existing, legally marketed devices.

The "Indications for Use" section specifies that the device is "For the quantitative determination of Low-density lipoprotein cholesterol (LDL-C) in human serum or plasma."

To adequately respond to your request for AI/ML device-specific information, I would need a document pertaining to an AI/ML medical device.

Ask a specific question about this device